Logo image of MASK

3 E NETWORK TECHNOLOGY GRP-A (MASK) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MASK - VGG8849D1107 - Common Stock

0.37 USD
-0.09 (-19.32%)
Last: 11/21/2025, 8:00:01 PM
0.3691 USD
0 (-0.24%)
After Hours: 11/21/2025, 8:00:01 PM
Fundamental Rating

5

MASK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 86 industry peers in the IT Services industry. MASK is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. MASK is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year MASK was profitable.
MASK had a positive operating cash flow in the past year.
MASK Yearly Net Income VS EBIT VS OCF VS FCFMASK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 500K 1M 1.5M

1.2 Ratios

With an excellent Return On Assets value of 48.78%, MASK belongs to the best of the industry, outperforming 98.84% of the companies in the same industry.
The Return On Equity of MASK (69.00%) is better than 96.51% of its industry peers.
Looking at the Return On Invested Capital, with a value of 69.88%, MASK belongs to the top of the industry, outperforming 98.84% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MASK is significantly above the industry average of 29.74%.
The last Return On Invested Capital (69.88%) for MASK is above the 3 year average (54.72%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 48.78%
ROE 69%
ROIC 69.88%
ROA(3y)38.06%
ROA(5y)N/A
ROE(3y)95.71%
ROE(5y)N/A
ROIC(3y)54.72%
ROIC(5y)N/A
MASK Yearly ROA, ROE, ROICMASK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 50 100

1.3 Margins

MASK has a Profit Margin of 34.04%. This is amongst the best in the industry. MASK outperforms 97.67% of its industry peers.
With an excellent Operating Margin value of 39.71%, MASK belongs to the best of the industry, outperforming 98.84% of the companies in the same industry.
Looking at the Gross Margin, with a value of 50.69%, MASK is in the better half of the industry, outperforming 74.42% of the companies in the same industry.
Industry RankSector Rank
OM 39.71%
PM (TTM) 34.04%
GM 50.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MASK Yearly Profit, Operating, Gross MarginsMASK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MASK is creating value.
Compared to 1 year ago, MASK has about the same amount of shares outstanding.
Compared to 1 year ago, MASK has an improved debt to assets ratio.
MASK Yearly Shares OutstandingMASK Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M 10M
MASK Yearly Total Debt VS Total AssetsMASK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M

2.2 Solvency

MASK has an Altman-Z score of 6.32. This indicates that MASK is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MASK (6.32) is better than 84.88% of its industry peers.
The Debt to FCF ratio of MASK is 0.13, which is an excellent value as it means it would take MASK, only 0.13 years of fcf income to pay off all of its debts.
MASK has a Debt to FCF ratio of 0.13. This is amongst the best in the industry. MASK outperforms 90.70% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that MASK is not too dependend on debt financing.
The Debt to Equity ratio of MASK (0.02) is better than 75.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.13
Altman-Z 6.32
ROIC/WACC8.13
WACC8.6%
MASK Yearly LT Debt VS Equity VS FCFMASK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.3 Liquidity

MASK has a Current Ratio of 2.14. This indicates that MASK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.14, MASK is in the better half of the industry, outperforming 63.95% of the companies in the same industry.
A Quick Ratio of 2.14 indicates that MASK has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.14, MASK is doing good in the industry, outperforming 63.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 2.14
MASK Yearly Current Assets VS Current LiabilitesMASK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 55.30% over the past year.
The Revenue has grown by 172.94% in the past year. This is a very strong growth!
EPS 1Y (TTM)55.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.65%
Revenue 1Y (TTM)172.94%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MASK Yearly Revenue VS EstimatesMASK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 1M 2M 3M 4M

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 1.61, the valuation of MASK can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of MASK indicates a rather cheap valuation: MASK is cheaper than 98.84% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of MASK to the average of the S&P500 Index (25.47), we can say MASK is valued rather cheaply.
Industry RankSector Rank
PE 1.61
Fwd PE N/A
MASK Price Earnings VS Forward Price EarningsMASK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MASK is valued cheaper than 98.84% of the companies in the same industry.
MASK's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MASK is cheaper than 96.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.74
EV/EBITDA 1.39
MASK Per share dataMASK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

MASK has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MASK!.
Industry RankSector Rank
Dividend Yield N/A

3 E NETWORK TECHNOLOGY GRP-A

NASDAQ:MASK (11/21/2025, 8:00:01 PM)

After market: 0.3691 0 (-0.24%)

0.37

-0.09 (-19.32%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.82%
Inst Owner ChangeN/A
Ins Owners68.44%
Ins Owner ChangeN/A
Market Cap4.16M
Revenue(TTM)7.69M
Net Income(TTM)2.62M
AnalystsN/A
Price TargetN/A
Short Float %3.88%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.61
Fwd PE N/A
P/S 0.54
P/FCF 3.74
P/OCF 3.74
P/B 1.1
P/tB 1.1
EV/EBITDA 1.39
EPS(TTM)0.23
EY62.16%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.1
FCFY26.77%
OCF(TTM)0.1
OCFY26.77%
SpS0.68
BVpS0.34
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.32
Profitability
Industry RankSector Rank
ROA 48.78%
ROE 69%
ROCE 78.73%
ROIC 69.88%
ROICexc 71.2%
ROICexgc 71.2%
OM 39.71%
PM (TTM) 34.04%
GM 50.69%
FCFM 14.49%
ROA(3y)38.06%
ROA(5y)N/A
ROE(3y)95.71%
ROE(5y)N/A
ROIC(3y)54.72%
ROIC(5y)N/A
ROICexc(3y)56.67%
ROICexc(5y)N/A
ROICexgc(3y)56.67%
ROICexgc(5y)N/A
ROCE(3y)61.65%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.43
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.13
Debt/EBITDA 0.03
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 36.41%
Profit Quality 42.57%
Current Ratio 2.14
Quick Ratio 2.14
Altman-Z 6.32
F-Score5
WACC8.6%
ROIC/WACC8.13
Cap/Depr(3y)97.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.14%
Cap/Sales(5y)N/A
Profit Quality(3y)109.93%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.65%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)172.94%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y78.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y65.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.48%
OCF growth 3YN/A
OCF growth 5YN/A

3 E NETWORK TECHNOLOGY GRP-A / MASK FAQ

Can you provide the ChartMill fundamental rating for 3 E NETWORK TECHNOLOGY GRP-A?

ChartMill assigns a fundamental rating of 5 / 10 to MASK.


Can you provide the valuation status for 3 E NETWORK TECHNOLOGY GRP-A?

ChartMill assigns a valuation rating of 5 / 10 to 3 E NETWORK TECHNOLOGY GRP-A (MASK). This can be considered as Fairly Valued.


Can you provide the profitability details for 3 E NETWORK TECHNOLOGY GRP-A?

3 E NETWORK TECHNOLOGY GRP-A (MASK) has a profitability rating of 6 / 10.